Lv2
136 积分 2024-12-03 加入
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
6天前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Site-specific mutagenesis screening in KRAS mutant library to uncover resistance mechanisms to KRASG12D inhibitors
2个月前
已完结
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
2个月前
已完结
Trabecular Bone Microarchitecture Evaluation in an Osteoporosis Mouse Model
2个月前
已完结
Genomic evolution of pancreatic cancer at single-cell resolution
4个月前
已完结
皖公网安备34019202002308
